Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT03233308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma or Ocular Hypertension

Interventions

DRUG: Netarsudil Ophthalmic Solution 0.02%
OTHER: Placebo Comparator

Sponsor

Aerie Pharmaceuticals